在调节上皮膜透性方面,Clostridium perfringens (c-CPE) 肠毒素 (c-CPE) 的转介,Cis抑制的悖论性活性
Julieta M Sanchez1,2,3,4, Marianna T P Favaro1,2, Hèctor López-Laguna1,2,5
1Institut de Biotecnologia i de Biomedicina (IBB), Universitat Autònoma de Barcelona, Barcelona 08193, Spain.
Molecular pharmaceutics
|March 11, 2025
概括
克洛斯特里透酶肠毒素 (c-CPE) 的C端域可以增强表皮透性,用于药物输送. 然而,当c-CPE与药物结合时,它起到屏障作用,阻碍自我运输.
科学领域:
- 生物技术是生物技术.
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 通过皮肤递送药物旨在提高患者的舒适度和治疗疗效.
- 紧结 (TJ) 连接体可以通过放松TJ蛋白质复合体来增强上皮质的透性.
- 克洛斯特里迪亚中毒素 (c-CPE) 的C终端域与关键TJ组成部分Claudins结合.
研究的目的:
- 评估c-CPE在模块化重组蛋白中促进对细胞上皮质通道的能力.
- 评估c-CPE作为通过皮肤递送药物的自动驾驶剂的潜力.
- 为了研究c-CPE介导的上皮膜通透的机制.
主要方法:
- 利用Caco-2细胞单层模型研究上皮质透性.
- 构建的模块化重组蛋白包含c-CPE功能域.
- 评估了融合蛋白质的细胞结合,细胞毒性和细胞间通道.
主要成果:
- 含有c-CPE的融合蛋白与细胞结合,但不会引起内部化或细胞毒性.
- 这些蛋白质促进了其他融合蛋白 (缺乏c-CPE) 在转移中的通道.
- 单独携带c-CPE的蛋白质无法穿过上皮质,这表明细胞间空间中的固定.
结论:
- 再组合c-CPE是一种有效的表皮透剂,当它被应用到缺乏c-CPE的分子时.
- c-CPE 抑制载体分子的半细胞移动性,使其不适合作为药物输送的自动驾驶器.
- 这些发现凸显了c-CPE在通过皮肤递送药物应用中的矛盾行为.
相关概念视频
01:52Eukaryotic Transcription Inhibitors
9.7K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.7K
02:13Cooperative Binding of Transcription Regulators
6.3K
Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome. Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
6.3K
02:37Disubstituted Cyclohexanes: cis-trans Isomerism
11.7K
Depending upon the different spatial orientation of the substituents, the disubstituted cycloalkanes exhibit two types of stereoisomers. The cis isomers have the substituents on the same side of the ring, whereas the trans isomers have the substituents on the opposite sides. These stereoisomers exhibit different physical properties and cannot be interconverted without breaking the carbon-carbon bonds.
In cyclohexane, the substituents can occupy different positions generating distinct isomers....
In cyclohexane, the substituents can occupy different positions generating distinct isomers....
11.7K
01:29The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
01:30Combined Effects of Drugs: Antagonism
8.2K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.2K
02:02Cis-regulatory Sequences
9.7K
Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
9.7K